Exelixis, Inc. is a company in the U.S. stock market and it is a holding in 108 U.S.-traded ETFs. EXEL has around 38.9M shares in the U.S. ETF market. The largest ETF holder of EXEL is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 8.23M shares. Investors may also find of interest that the ETF with the largest allocation to EXEL stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 3.86%. On average, U.S. ETFs allocate 0.36% of EXEL to their portfolios.

Additionally, EXEL is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with EXEL as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 45.12%.